Literature DB >> 12487774

Cost estimation of thyroid disorders in Germany.

George J Kahaly1, Markus Dietlein.   

Abstract

To assess the economic effects of thyroid disorder-related morbidity in Germany, a systematic review of national and international literature from 1981-2001 was performed. Data from insurance companies, the government department of public health, and the federal office of statistics helped characterize the situation in Germany. Being the most important thyroid disease, endemic iodine-deficiency goiter causes economic costs of approximately 2.1 billion DM per year or 1 billion Euros or 1 billion U.S. dollars. In recent years iodine supplementation of food became better accepted by the German population. This should significantly reduce the prevalence of goiter from 30%-40% to less than 10%. Functional thyroid disorders are observed in 5%-10% of the German population. A more differentiated view of these conditions should lead to specific guidelines for an economic screening and therapy of subpopulations. Lacking valuable data, an actual economic assessment of autoimmune or malignant thyroid diseases cannot be performed. On the other hand, with respect to the costs of specific thyroid therapy, e.g., radioiodine treatment of thyrotoxicosis (mainly toxic nodular goiter), the economic consequences of a new regulation for radiation protection in Germany have been demonstrated recently. Using the actual maximum permissible level of residual activity on discharge from the hospital after radioiodine therapy, length of hospitalization was shortened to 5.1 days in university hospitals and to 5.8 days in nonuniversity institutions. Payment per patient for radioiodine therapy was 1,856 and 1,530 Euros (median value) in university and nonuniversity hospitals, respectively. In conclusion, better prevention of iodine deficiency and its long-term consequences should effectively reduce direct as well as indirect costs and overall economic impact of endemic goiter as the most important thyroid disease in Germany. Sustainable elimination of iodine deficiency is technically possible, but it needs further commitment and support at all levels.

Entities:  

Mesh:

Year:  2002        PMID: 12487774     DOI: 10.1089/105072502761016548

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  10 in total

Review 1.  [Diagnosis and therapy of thyroid nodules].

Authors:  A Tönjes; R Paschke
Journal:  Internist (Berl)       Date:  2005-05       Impact factor: 0.743

2.  Long-term lithium treatment and thyroid antibodies: a controlled study.

Authors:  Christopher Baethge; Holger Blumentritt; Anne Berghöfer; Tom Bschor; Tasha Glenn; Mazda Adli; Peter Schlattmann; Michael Bauer; Reinhard Finke
Journal:  J Psychiatry Neurosci       Date:  2005-11       Impact factor: 6.186

Review 3.  [Clinical pathways in endocrinology and diabetology].

Authors:  B Gallwitz; H Lehnert; H Dittmann; J Honegger; R Teichmann; M Tatagiba; H U Häring
Journal:  Internist (Berl)       Date:  2006-07       Impact factor: 0.743

4.  Thiocyanate status does not play a role in the etiology of residual goiter in school children of Isfahan, Iran.

Authors:  Ammar H Keshteli; Mahin Hashemipour; Mansour Siavash; Masoud Amini
Journal:  World J Pediatr       Date:  2010-11-16       Impact factor: 2.764

Review 5.  [Therapy and prevention of hyperthyroidism].

Authors:  U Woenckhaus; C Girlich
Journal:  Internist (Berl)       Date:  2005-12       Impact factor: 0.743

Review 6.  Iodine, thyroglobulin and thyroid gland.

Authors:  R Bílek; M Dvořáková; T Grimmichová; J Jiskra
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

7.  Hormonally Active Contraceptives, Part II: Sociological, Environmental, and Economic Impact.

Authors:  William V Williams; Joel Brind; Laura Haynes; Michael D Manhart; Hanna Klaus; Angela Lanfranchi; Gerard Migeon; Michael Gaskins; Elvis I Šeman; Lester Ruppersberger; Kathleen M Raviele
Journal:  Linacre Q       Date:  2021-04-21

8.  Quality of life and occupational disability in endocrine orbitopathy.

Authors:  Katharina A Ponto; Susanne Pitz; Norbert Pfeiffer; Gerhard Hommel; Matthias M Weber; George J Kahaly
Journal:  Dtsch Arztebl Int       Date:  2009-04-24       Impact factor: 5.594

9.  The economic impact of prevention, monitoring and treatment strategies for iodine deficiency disorders in Germany.

Authors:  Monika Schaffner; Ursula Rochau; Nikolai Mühlberger; Annette Conrads-Frank; Vjollca Qerimi Rushaj; Gaby Sroczynski; Eftychia Koukkou; Betina Heinsbaek Thuesen; Henry Völzke; Wilhelm Oberaigner; Uwe Siebert
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

10.  Short- and medium-term cost effects of non-indicated thyroid diagnostics: empirical evidence from German claims data.

Authors:  Lucas Hafner; Valeria Biermann; Susann Hueber; Ewan Donnachie; Thomas Kühlein; Harald Tauchmann; Johanna Tomandl
Journal:  Eur J Health Econ       Date:  2021-11-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.